AMENDMENT #1
Published: 08/03/2009
Description
IOM_9_slides_print_MMcadams_012808_final.pdf January 29, 2008 FDA/CDER/OSE 1 Timing and characteristics of safety-related actions for new molecular entities (1991-2006): A preliminary study Mara McAdams, MS Epidemiology and Policy Fellow ...
